Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial

被引：0
|
作者：
Chit Moy Ley
Qing Ni
Xing Liao
Huai-lin Gao
Nicola Robinson
机构：
[1] London South Bank University,School of Health and Social Care
[2] China Academy of Chinese Medical Sciences,Department of Endocrinology, Guang’anmen Hospital
[3] China Academy of Chinese Medical Sciences,Institute of Basic Research in Clinical Medicine
[4] Yiling Hospital Affiliated to Hebei Medical University,Department of Endocrinology
来源：
Chinese Journal of Integrative Medicine | 2016年 / 22卷
关键词：
cardiovascular disease; fibrinogen; diabetes; bromelain; randomized control trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：728 / 737
页数：9
相关论文
共 50 条
  • [1] Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial
    Ley, Chit Moy
    Ni Qing
    Liao Xing
    Gao Huai-lin
    Robinson, Nicola
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2016, 22 (10) : 728 - 737
  • [2] Bromelain and Cardiovascular Risk Factors in Diabetes:An Exploratory Randomized,Placebo Controlled,Double Blind Clinical Trial
    黎七妹
    倪青
    廖星
    高怀林
    Nicola Robinson
    Chinese Journal of Integrative Medicine, 2016, 22 (10) : 728 - 737
  • [3] The effect of bromelain in periodontal surgery: a double-blind randomized placebo-controlled trial
    Babazade, Hossein
    Mirzaagha, Arad
    Konarizadeh, Shokoofeh
    BMC ORAL HEALTH, 2023, 23 (01)
  • [4] The effect of bromelain in periodontal surgery: a double-blind randomized placebo-controlled trial
    Hossein Babazade
    Arad Mirzaagha
    Shokoofeh Konarizadeh
    BMC Oral Health, 23
  • [5] Contributions of vitamin D in the management of depressive symptoms and cardiovascular risk factors: study protocol for a randomized, double-blind, placebo-controlled clinical trial
    Catarina Magalhães Porto
    Tatiana de Paula Santana da Silva
    Everton Botelho Sougey
    Trials, 20
  • [6] Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial
    Hadi, Saeid
    Daryabeygi-Khotbehsara, Reza
    Mirmiran, Parvin
    McVicar, Jenna
    Hadi, Vahid
    Soleimani, Davood
    Askari, Gholamreza
    PHYTOTHERAPY RESEARCH, 2021, 35 (07) : 3747 - 3755
  • [7] Cardiovascular and osteoporosis protection at menopause with lycopene: A placebo-controlled double-blind randomized clinical trial
    Meeta, Meeta
    Sharma, Sudhaa
    Unni, Jyothi
    Khandelwal, Sunila
    Choranur, Ambuja
    Malik, Sonia
    JOURNAL OF MID-LIFE HEALTH, 2022, 13 (01) : 50 - 56
  • [8] Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial
    Sasaki, M.
    Imaeda, K.
    Okayama, N.
    Mizuno, T.
    Kataoka, H.
    Kamiya, T.
    Kubota, E.
    Ogasawara, N.
    Funaki, Y.
    Mizuno, M.
    Iida, A.
    Goto, C.
    Koikeda, S.
    Kasugai, K.
    Joh, T.
    DIABETES OBESITY & METABOLISM, 2012, 14 (04) : 379 - 382
  • [9] Effects of sea buckthorn puree on risk factors of cardiovascular disease in hypercholesterolemia population: a double-blind, randomized, placebo-controlled trial
    Zhou, Fangfei
    Zhang, Jian
    Zhao, Ai
    Zhang, Yumei
    Wang, Peiyu
    ANIMAL BIOTECHNOLOGY, 2022, 33 (05) : 955 - 963
  • [10] The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled clinical trial
    Darand, Mina
    Darabi, Zahra
    Yari, Zahra
    Hedayati, Mehdi
    Shahrbaf, Mohammad Amin
    Khoncheh, Ahmad
    Hosseini-Ahangar, Behnam
    Alavian, Seyed Moayyed
    Hekmatdoost, Azita
    PHYTOTHERAPY RESEARCH, 2019, 33 (09) : 2369 - 2377
12345